BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a global biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced that clinical results from its broad hematology program will be presented at the 26 th European Hematology Association 2021 (EHA2021) Virtual Congress being held June 9 – 17, 2021.
May 12, 2021
· 12 min read